GenomeWeb Index Rises in March as Some Firms Post Positive Q4 Results | GenomeWeb

NEW YORK (GenomeWeb) – The GenomeWeb Index rose 6.4 percent in March, as the majority of the stocks posted gains, some significant.

The GenomeWeb Index performed roughly in line with the Dow Jones Industrial Average, which gained 7.1 percent during the month, and the Nasdaq, which gained 6.8 percent. It significantly outperformed the Nasdaq Biotechnology Index, which finished the month 2.5 percent higher.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.